ArticleBlood2023

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma.

Blandine Pouleau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.